While both Wegovy and Ozempic list “headache” as a common side effect that was found during the drugs’ clinical trials, many ...

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight ...

A MOUNJARO user has claimed that after 19 weeks of injecting, she is “too scared to move away from the toilet” as a result of ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...